- Using Tesla Math, GM’s Buick Unit Should Be Worth $1.1 Trillion
- No, Tesla Does Not Outsell the Mercedes S-Class in the U.S. or Globally
- The 10 Most 'Socialist' States in America
- Will Bendgate Have Any Long-Term Effect on Apple's iPhone 6 Plus Legacy?
- TheStreet Seeks Retraction From Washington Post on Steven Pearlstein Column
Spectrum's Beleodaq for Non-Hodgkin's lymphoma received FDA approval on July 3, but the stock then fell 26%. The same thing won't happen with Melphalan because sales numbers are already established.
Toyota is scrapping its electric vehicle line to go into fuel cells. Is this a step backwards? Not really.
Vertex Pharmaceuticals is now within weeks, or even days, of announcing top-line results on its two phase 3 cystic fibrosis studies. The science, phase 2 data, and FDA approval history for cystic fibrosis all suggest that Vertex is about to explode higher.